EVP, Chief Financial Officer
Sat, Mar 1, 2025
Mar 1
received an award in NTLA
47,200 shares @ $0.00
Increased holdings by +71.20%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+6.20%
1M+19.66%
3M+1.82%
6M—
1Y—